MediciNova, Inc.

NASDAQ:MNOV

1.82 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 104.03800000006.0030.8030000263.8770.2640.8040.49000
Cost of Revenue 0.020.21200.0210.0240.0260.0280.0140.0270000000146.6070.1470.6740.438000
Gross Profit 0.98-0.2124.038-0.021-0.024-0.026-0.028-0.014-0.02706.0030.8030000117.270.1170.130.053000
Gross Profit Ratio 0.980100000001100000.4440.4440.1610.107000
Reseach & Development Expenses 5.6589.1448.5387.4856.0795.6264.2243.5193.0173.263.3665.0137.7859.71110.87313.82842.12132.17122.73811.3174.7235.5510.952
General & Administrative Expenses 5.2425.4855.7156.6937.9529.9618.8037.3635.8055.9636.6586.7358.3248.17210.3668.77411.3739.6247.4793,160.306000
Selling & Marketing Expenses 0000000000000000000-3,122.958000
SG&A 5.2425.4855.7156.6937.9529.9618.8037.3635.8055.9636.6586.7358.3248.17210.3668.77411.3739.6247.47937.3481.5381.4620
Other Expenses -0.503-0.247-0.059-0.038-0.046-0.0230.120.02-0.0150.024-0.004-0.005000000439.15737.348000
Operating Expenses 10.914.62914.25314.17814.03115.58713.02710.8828.8229.22310.02411.74816.10817.88321.23922.60153.49441.79530.21748.6656.2617.0132.015
Operating Income -9.9-14.629-10.216-14.178-14.031-15.587-13.027-10.882-8.822-9.223-4.021-10.945-16.108-17.883-21.239-22.601-53.494-41.678-30.088-48.612-6.261-7.013-2.015
Operating Income Ratio -9.90-2.530000000-0.67-13.6380000-0.203-157.943-37.419-99.152000
Total Other Income Expenses Net -0.5030.5620.0840.3231.102-0.0230.120.02-0.0150.024-0.004-0.005-0.019-0.5230.878-1.3484.6115.9884.3960.340.0520.0820
Income Before Tax -8.568-14.066-10.132-13.856-12.929-14.67-12.907-10.862-8.838-9.199-4.024-10.95-17.723-20.175-20.362-21.911-48.883-35,689.611-25,692.135-48,272.603-6.209-6.9310
Income Before Tax Ratio -8.5680-2.5090000000-0.67-13.6440000-0.185-135,250.935-31,952.689-98,458.852000
Income Tax Expense 0.0030.0030.003-0.0020.0130.005-1.7440.0040.007-0.0040.0040.0110.0120.0130.0070.0140.02-5.68-3.68-0.34-0.05201.795
Net Income -8.572-14.069-10.134-13.854-12.942-14.675-11.163-10.866-8.845-9.195-4.029-10.961-17.734-20.187-20.369-21.925-48.903-35.69-25.692-48.273-6.209-6.931-1.795
Net Income Ratio -8.5720-2.510000000-0.671-13.6580000-0.185-135.251-31.953-98.459000
EPS -0.17-0.29-0.21-0.31-0.3-0.36-0.32-0.33-0.33-0.38-0.19-0.64-1.2-1.63-1.68-1.82-4.16-3.52-2.88-965.45-124.18-138.62-35.9
EPS Diluted -0.17-0.29-0.21-0.31-0.3-0.36-0.32-0.33-0.33-0.38-0.19-0.64-1.2-1.63-1.68-1.82-4.16-3.52-2.88-965.45-124.18-138.62-35.9
EBITDA -9.88-14.611-10.19-14.157-14.007-15.561-12.879-10.848-8.811-9.158-3.92-10.95-16.067-17.775-21.898-20.948-57.759-47.665-34.483-48.907-6.283-7.095-2.015
EBITDA Ratio -9.880-2.5240000000-0.653-13.6440000-0.219-180.635-42.886-99.753000